Experience

Davis Polk advised the joint bookrunners in connection with an SEC-registered offering of $1.5 billion aggregate principal amount of 5.750% perpetual additional tier 1 contingent…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Encore Capital Group, Inc. of $100 million principal amount of 3.25% convertible senior notes due 2025…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Insulet Corporation of $800 million principal amount of 0.375% convertible senior notes due 2026,…

Davis Polk advised Banco Bilbao Vizcaya Argentaria, S.A. on its SEC-registered offering of $1 billion liquidation preference of series 9 non-step-up non-cumulative contingent convertible…

Davis Polk advised Uniti Group Inc. (“Uniti Group”) and Uniti Fiber Holdings Inc. (“Uniti Fiber,” and together with Uniti Group, “Uniti”) in connection with a Rule 144A offering of $345…

Davis Polk advised the initial purchasers in connection with a Rule 144A and Regulation S offering by YY Inc. (NASDAQ: YY) of $425 million aggregate principal amount of 0.750% convertible…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Zynga Inc. of $690 million aggregate principal amount of its 0.25% convertible senior notes due 2024,…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Coupa Software Incorporated of $805 million aggregate principal amount of its 0…

Davis Polk advised the initial purchasers in connection with Rule 144A offerings by IAC FinanceCo 2, Inc. and IAC FinanceCo 3, Inc., wholly owned subsidiaries of IAC/InterActiveCorp (“IAC”)…

Davis Polk advised the representatives of the several underwriters in connection with the SEC-registered offering of 2,760,000 shares of common stock of Intercept Pharmaceuticals, Inc. …